Hemgenix has actually been offered ‘conditional authorisation’. This means that the European Medicines Agency decided that the many benefits of Hemgenix are better than its challenges, but the company must present added evidence following authorisation.Professionals observed that the number of individuals predicted to receive etranacogene dezap